02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 79.75
−0.99%Leverage
- Debt / equity
- 0.17x
- Net debt / equity
- -0.41x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.83x
- Net debt / EBITDA
- 1.98x
Liquidity & coverage
- Current ratio
- 4.83x
- Quick ratio
- 4.55x
- Cash ratio
- 3.97x
- Interest coverage
- -61.69x
- EBITDA / interest
- -53.67x
- Working capital
- HKD 3.6B
Cash & dividend
- FCF / debt
- -2.02x
- Cash flow / debt
- -1.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026